Previous 10 | Next 10 |
PARIS and CAMBRIDGE, Mass., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “company”), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative...
Sarconeos (BIO101) at the highest dose (350 mg bid) showed a clinically meaningful improvement in the 400-meter walk test (400MWT), the primary endpoint of the study Sarconeos (BIO101) showed a very good safety profile at the doses of 175 mg bid and of 350 mg bid with no Serious Adver...
PARIS and CAMBRIDGE, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative...
Biophytis (BPTS) announces new positive preclinical data on Sarconeos (BIO101) in hamsters infected with SARS-CoV-2. In the study, hamsters were inoculated intranasally with 106 TCID50/mL. Sarconeos (BIO101) was administered daily at 10 mg/kg*day. In animals treated with Sarconeos (BIO101), t...
PARIS and CAMBRIDGE, Mass., July 12, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “company”), a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing...
Biophytis (BPTS) announces two new appointments of healthcare executives. Benoit Canolle has been named chief business officer, or CBO, and will be member of the executive committee. Jean Mariani, chairman of the Biophytis scientific committee will replace Sam Agus as chief medical offic...
Claude Allary to be member of Board of Directors Benoit Canolle is appointed Chief Business Officer Jean Mariani, Chairman of Biophytis Scientific Committee to take over the Chief Medical Officer role PARIS and CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -...
The Company signed contracts for the manufacturing of registration batches in view of the potential application for Emergency Use Authorization to FDA and/or Conditional Marketing Authorization to EMA The 155 th patient has completed treatment in Part 2 of the COVA P...
PARIS and CAMBRIDGE, Mass., June 30, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “company”),a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing ...
PARIS and Cambridge, Mass., June 19, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a clinical-stage biotechnology company focused on the development of therapeutics aimed at slowing the dege...
News, Short Squeeze, Breakout and More Instantly...
Biophytis SA Company Name:
BPTS Stock Symbol:
NASDAQ Market:
ADSs delisted from Nasdaq, which will result in meaningful savings ADSs transferred to OTC Pink market; Company will apply to trade on OTCQB market Biophytis remains listed on Euronext Growth Paris as its primary trading market PARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE / April 2...
A look at the top 10 most actives in the United States Cyngn Inc. (CYN) rose 90.2% to $0.2302 on volume of 145,513,222 shares Pineapple Energy Inc. (PEGY) rose 47.8% to $0.0677 on volume of 101,675,442 shares AGBA Group Holding Limited (AGBA) rose 8.7% to $2.7186 on volume of 17,457,670 s...
2024-04-22 09:02:03 ET Biophytis (BPTS) announced stock split at a ratio of 1-for-40 on 2024-04-23 ... Full story available on KlickAnalytics.com